Vivek Rangnekar's Research Laboratory
Left to Right: Nikhil Hebbar, James Sledziona, Ping Du, Ablesh Gautam, Tripti Shrestha-Bhattarai, Hannah Latta, Vivek Rangnekar, Nathalia Vitori Araujo, Sunil Nooti, Ravshan Burikhanov.
Shuxia Wang receives RO1 funding
Shuxia Wang, MD, Ph.D., has received NIH RO1 funding for a project titled "Thrombospondin1 in obesity associated inflammation and insulin resistance." The project will be supported by $1,204,651 grant for the period of August 2014 to May 2018. In addition, Dr. Wang recently received a competitive score for an R03 award to study interventions that may reduce acute kidney injury in the elderly. Dr. Wang joined the University of Kentucky faculty in 2005, and has served extensively in the areas of research, graduate training, and education. Dr.
UK HealthCare to Open New Inpatient Cardiovascular Unit
Markesbery Symposium Presents Latest Research on Aging and Dementia
CCTS Appalachian Translational Research Network publishes fall issue of Community Voice
Changcheng Zhou's R21 grant awarded funding
Changcheng Zhou, PhD, assistant professor of Pharmacology and Nutritional Sciences, has received funding for an NIH R21 grant: "Mechanisms of atherogenic effects of bisphenol A," for the period April 1, 2014 - March 31, 2016. Dr. Zhou joined the faculty of University of Kentucky in 2010. He also holds an adjunct faculty position at Rockefeller University, NY. The main focus of Dr. Zhou’s laboratory is to investigate the molecular mechanisms of atherosclerosis and metabolic disorders.